Stock PETQ PETIQ, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company PetIQ, Inc.

Equities

PETQ

US71639T1060

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-06 pm EDT 		5-day change 1st Jan Change
17.65 USD +3.58% Intraday chart for PetIQ, Inc. +7.49% -10.63%
Mar. 14 PetIQ, Inc. Announces Expansion of Minties Dental Treats Brand with Launch of New Dental Chew for Large-Sized Dogs CI
Feb. 28 Transcript : PetIQ, Inc., Q4 2023 Earnings Call, Feb 28, 2024

Business Summary

PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.

Number of employees: 1,527

Sales per Business

USD in Million2022Weight2023Weight Delta
Products
87.9 %
800 86.8 % 968 87.9 % +20.97%
Services
12.1 %
121 13.2 % 134 12.1 % +10.40%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
99.3 %
915 99.3 % 1,094 99.3 % +19.63%
Foreign
0.7 %
7 0.7 % 8 0.7 % +13.48%

Managers

Managers TitleAgeSince
McCord Christensen CEO
 Chief Executive Officer 51 09-12-31
Michael Smith PSD
 President 46 19-06-30
Zvi Glasman DFI
 Director of Finance/CFO 60 22-01-02
Darrin Harris CTO
 Chief Tech/Sci/R&D Officer - -
Lauren Olavessen CTO
 Chief Tech/Sci/R&D Officer - 20-02-02
John Pearson PRN
 Corporate Officer/Principal 37 21-12-31
Pat Jones AUD
 Comptroller/Controller/Auditor - 15-06-30
Jeff Caywood SEC
 Corporate Secretary - -
Chad Lyon PRN
 Corporate Officer/Principal - 15-11-30
Nathan Lembke SAM
 Sales & Marketing - -

Members of the board

Members of the board TitleAgeSince
Mark First BRD
 Director/Board Member 59 17-07-25
Sheryl O'Loughlin BRD
 Director/Board Member 57 21-03-01
McCord Christensen CEO
 Chief Executive Officer 51 09-12-31
Scott Huff BRD
 Director/Board Member 52 18-12-31
Kimberly Lefko BRD
 Director/Board Member 51 21-03-01
Kenneth Walker BRD
 Director/Board Member 49 22-01-02
Allan Hall BRD
 Director/Board Member 60 22-04-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 231,540 0 0 91.30 %
Stock B 1 29,856,235 27,470,223 ( 92.01 %) 373,000 ( 1.249 %)

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
9.342 %
2,726,741 9.342 % 50 M $
Vanguard Fiduciary Trust Co.
7.358 %
2,147,759 7.358 % 39 M $
Eos Partners LP
6.759 %
1,972,687 6.759 % 36 M $
James Clarke
5.793 %
1,690,802 5.793 % 31 M $
Aristotle Capital Boston LLC
4.414 %
1,288,415 4.414 % 24 M $
Dimensional Fund Advisors LP
3.723 %
1,086,625 3.723 % 20 M $
Goldman Sachs Asset Management LP
3.550 %
1,036,292 3.550 % 19 M $
Boston Partners Global Investors, Inc.
3.426 %
999,880 3.426 % 18 M $
Nepsis, Inc.
3.077 %
898,169 3.077 % 16 M $
Driehaus Capital Management LLC
2.508 %
732,155 2.508 % 13 M $
NameEquities%Valuation
Christensen Ventures, LLC
45.15 %
114,027 45.15 % 2 M $

Company contact information

PetIQ, Inc.

230 East Riverside Drive

83616, Eagle

+208 939 8900

http://www.petiq.com
address PetIQ, Inc.(PETQ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Veterinary Drugs

Sales per Business

Sales per region

Ratings for PetIQ, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
17.04 USD
Average target price
29 USD
Spread / Average Target
+70.19%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Veterinary Drugs

1st Jan change Capi.
PETIQ, INC. Stock PetIQ, Inc.
-10.63% 502M
ZOETIS INC. Stock Zoetis Inc.
-15.92% 76.23B
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
-11.01% 6.67B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+27.50% 3.7B
VIRBAC Stock Virbac
-1.25% 3.21B
VIMIAN GROUP AB Stock Vimian Group AB
+4.73% 1.52B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-13.83% 1.37B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-23.86% 1.24B
VETOQUINOL SA Stock Vetoquinol SA
-8.01% 1.21B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-8.44% 1.17B
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. PETQ Stock
  4. Company PetIQ, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW